Featured
Today’s a big day at Current, which is saying a lot considering the year we’ve had. Today, we’re announcing that we’ve received Class II clearance from the U.S. Food and Drug Administration (FDA)...
Read moreMy personal HIMSS experience started out with a first for me – a live TV interview. It was a great way to kick off the conference. I also participated in a panel discussion on digital healthcare transformation,...
Read more